PM360

NOVEMBER 29, 2022

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. But that’s just the beginning.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

Clarivate

JUNE 21, 2024

They differ from traditional literature reviews in that they typically adhere to strict methodological guidelines such as those issued by the Cochrane Collaboration (Cochrane, 2019) and the Centre for Reviews & Dissemination (Centre for Reviews and Discussion, 2009). CRDs guidance for undertaking reviews in healthcare.

Training 81

Training Government Medical science Ethics 81

Pharmaceutical Technology

NOVEMBER 3, 2022

Cardiovascular medicines were ranked as the sixth most affected drug class by shortages, as per a 2019 European Association of Hospital Pharmacists (EAHP) survey, says the organisation’s director of finance, Nenad Miljkovi?. To me, even [if] a shortage has resolved, it is only a matter of time until it happens again,” he explains.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111

European Pharmaceutical Review

MAY 2, 2023

In 2019, the pharmaceutical industry spent $83 billion on R&D, which is about 10 times what the industry spent per year in the 1980s, 4 yet the average duration to develop a new medicine is still around 10-15 years. About the authors Dr Nils Eckardt joined BeiGene in February 2019 as Vice President, Medical Affairs, Europe.

Patients 105

Patients Medicine Marketing Medical 105

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. 8 Future potential Celltrion sees potential for the platform to be applicable to other biologics, according to SungHyun Kim, Head of the company’s Medical Science Division. 2019 [cited 2023Feb].

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

Veeva

FEBRUARY 6, 2022

According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1. Veeva Pulse analysis. Across Health and Veeva: Intelligent HCP Engagement.

Pharma 52

Pharma Medical Consulting Pharma reps 52